Understanding participant experiences and preferences in an injectable PrEP trial: a qualitative sub-study of barriers, facilitators and preferences for PrEP use among MSM and TGW

被引:0
|
作者
Psaros, C. [1 ]
Landovitz, R. J. [2 ]
Rice, W. [3 ,4 ]
Kelley, C. F. [4 ,5 ]
Oyedele, T. [6 ,7 ,8 ]
Coelho, L. [9 ]
Phanuphak, N. [10 ]
Singh, Y. [11 ,12 ]
Middelkoop, K. [11 ,12 ]
Griffith, S. [13 ]
McCauley, M. [13 ]
Goodman, G. [1 ,14 ]
Rooney, J. [15 ]
Rinehart, A. [16 ]
Van de Velde, N. [17 ]
Clark, J. [18 ]
Go, V. [19 ]
Sugarman, J. [20 ,21 ]
Fields, S. [22 ]
Gordon, C. [23 ]
Adeyeye, A. [24 ]
Grinsztejn, B. [9 ]
Safren, S. A. [25 ]
机构
[1] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA
[2] UCLA Ctr Clin AIDS Res & Educ, Div Infect Dis, Los Angeles, CA USA
[3] Emory Univ, Dept Behav Social & Hlth Educ Sci, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[4] Emory Vaccine Ctr, Hope Clin, Decatur, GA USA
[5] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA
[6] Ruth M Rothstein CORE Ctr, Adolescent & Young Adult Res, Chicago, IL USA
[7] Ruth M Rothstein CORE Ctr, Chicago, IL USA
[8] John H Stroger Jr Hosp Cook Cty, Div Infect Dis, Chicago, IL USA
[9] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil
[10] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand
[11] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, Cape Town, South Africa
[12] Univ Cape Town, Dept Med, Cape Town, South Africa
[13] FHI 360, HIV Prevent Trials Network, Durham, NC USA
[14] Fenway Hlth, Fenway Inst, Boston, MA USA
[15] Gilead Sci, Foster City, CA USA
[16] ViiV Healthcare, Durham, NC USA
[17] ViiV Healthcare, Brentford, England
[18] UCLA David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA USA
[19] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA
[20] Johns Hopkins Univ, Berman Inst Bioeth, Sch Med, Baltimore, MD USA
[21] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[22] Penn State Coll Nursing, University Pk, PA USA
[23] NIMH, NIH, HIV Prevent & Care Continuum, Comorbid & Translat Res Branch, Rockville, MD 20857 USA
[24] NIAID, NIH, Div Aids, Rockville, MD USA
[25] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OALC0503
引用
收藏
页码:30 / 30
页数:1
相关论文
共 46 条
  • [21] Factors influencing the willingness to use bi-monthly long-acting injectable PrEP among MSM using oral PrEP: Results from a mixed-method study in Belgium
    Reyniers, T.
    Rotsaert, A.
    Nostlinger, C.
    Hensen, B.
    Vuylsteke, B.
    [J]. HIV MEDICINE, 2023, 24 : 511 - 511
  • [22] Barriers and facilitators to oral PrEP uptake among high-risk men after HIV testing at workplaces in Uganda: a qualitative study
    Racheal Nabunya
    Victoria M. S. Karis
    Lydia Joslyline Nakanwagi
    Pius Mukisa
    Patience A. Muwanguzi
    [J]. BMC Public Health, 23
  • [23] Facilitators and barriers to infant post-natal HIV prophylaxis, a qualitative sub-study of the PROMISE-EPI trial in Lusaka, Zambia
    Mennecier, Anais
    Matoka, Beauty
    Wilfred-Tonga, Maria Melany
    Chunda-Liyoka, Catherine
    Mwiya, Mwiya
    Nagot, Nicolas
    Moles, Jean-Pierre
    van de Perre, Philippe
    Kankasa, Chipepo
    King, Rachel
    PROMISE EPI Social Sci Sub Study Grp
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [24] Awareness of and Preferences for Preexposure Prophylaxis (PrEP) among MSM at High Risk of HIV Infection in Southern China: Findings from the T2T Study
    Chen, Weiying
    Ding, Yi
    Chen, Jianghao
    Zhao, Peipei
    Wang, Zhenyu
    Meng, Xiaojun
    Jia, Tianjian
    Zheng, Heping
    Yang, Bin
    Luo, Zhenzhou
    Zou, Huachun
    [J]. BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [25] Transgender Women’s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)
    Christine Tagliaferri Rael
    Javier Lopez-Ríos
    Stacey A. McKenna
    Doyel Das
    Curtis Dolezal
    Elena Abascal
    Alex Carballo-Diéguez
    Rebecca Schnall
    Thomas J. Hope
    José Bauermeister
    Walter Bockting
    [J]. AIDS and Behavior, 2021, 25 : 4180 - 4192
  • [26] Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study
    Schoenberg, Paige
    Edwards, O. Winslow
    Merrill, Leland
    Martinez, Cristian Acero
    Stephenson, Rob
    Sullivan, Patrick S.
    Jones, Jeb
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26 (03)
  • [27] Transgender Women's Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)
    Rael, Christine Tagliaferri
    Lopez-Rios, Javier
    McKenna, Stacey A.
    Das, Doyel
    Dolezal, Curtis
    Abascal, Elena
    Carballo-Dieguez, Alex
    Schnall, Rebecca
    Hope, Thomas J.
    Bauermeister, Jose
    Bockting, Walter
    [J]. AIDS AND BEHAVIOR, 2021, 25 (12) : 4180 - 4192
  • [28] Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework
    K. Rivet Amico
    Melissa Wallace
    Linda-Gail Bekker
    Surita Roux
    Millicent Atujuna
    Elaine Sebastian
    Bonnie J. Dye
    Vanessa Elharrar
    Robert M. Grant
    [J]. AIDS and Behavior, 2017, 21 : 1361 - 1375
  • [29] Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework
    Amico, K. Rivet
    Wallace, Melissa
    Bekker, Linda-Gail
    Roux, Surita
    Atujuna, Millicent
    Sebastian, Elaine
    Dye, Bonnie J.
    Elharrar, Vanessa
    Grant, Robert M.
    [J]. AIDS AND BEHAVIOR, 2017, 21 (05) : 1361 - 1375
  • [30] Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States
    Kerrigan, D.
    Mantsios, A.
    Grant, R.
    Markowitz, M.
    Defechereux, P.
    La Mar, M.
    Beckham, S. W.
    Hammond, P.
    Margolis, D.
    Murray, M.
    [J]. AIDS AND BEHAVIOR, 2018, 22 (11) : 3540 - 3549